Charles Y Lin insider trades
Open-market stock purchases and sales by Charles Y Lin, Chief Scientific Officer at Kronos Bio, Inc, from SEC Form 4 filings since Feb 21, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- KRON Kronos Bio, Inc: 1 sale, last Oct 15, 2024